Pharma — December 2025
-
The Healthcare Sector Is Surging. Here's 1 Stock Every Investor Should Have on Their Radar. https://proinvestor.com/investornyt/1390543/the-healthcare-sector-is-surging-heres-1-stock-every-investor-should-have-on-their-radar
-
Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting
· New long-term data presented at AES 2025 indicate reductions in seizure frequency are
News Powered by Cision (news.cision.com)
-
Lundbeck viser langvarig virkning med middel mod svære epilepsilidelser https://proinvestor.com/investornyt/1390914/lundbeck-viser-langvarig-virkning-med-middel-mod-svaere-epilepsilidelser
-
Novo: Flere medicinalselskaber rygtes på vej til at indgå aftaler om lavere priser i USA https://proinvestor.com/investornyt/1395434/novo-flere-medicinalselskaber-rygtes-pa-vej-til-at-indga-aftaler-om-lavere-priser-i-usa
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind